First time on a plane.
Release time:
2020-07-22
It's the first time to fly
At home, I can often hear so-and-so talking about the experience of flying with great interest. It seems to be a great thing. Indeed, that's what I think in my heart, because I haven't been on a plane yet. Moreover, several of our brothers and sisters have been seated by others. when we got together, we talked about the show-off-flying to Kunming the day before, flying back to Simao the next morning, eating a bowl of famous dried peanuts, and then going home to make a cup of home-grown coffee. how cool! It sounds envious and angry.
When can I personally experience a flight?
Last year, the company arranged four people to go to Dali to take the qualification examination, and I was among them. Hearing this news, I was really excited-Dali is a good place to travel, and it is good to sit on the "big iron bird. This excitement washed away all the nervousness of having to take the exam.
Finally, on the day of departure, we will take the plane from Xishuangbanna to Dali, which will take off at 10 50 in the morning. My colleagues and I arrived at the airport two hours early, lined up to get our boarding passes, and then entered the terminal. The waiting hall is not big, only a few people are scattered, looking clean and tidy. Very not easy to wait until the departure, the boarding line was very long, and a beautiful stewardess at the boarding gate greeted every passenger with a smile. Entering the cabin, the eyes were full of neat three-seat double-row seats, and the aisle was clean and comfortable. When I found my seat and sat down, my curiosity broke out. I took out my cell phone and took all kinds of pictures.
After the flight attendant began to play the precautions after boarding, the plane began to taxi on the runway, faster and faster, and finally rose into the air. It was obvious that the front was high and the back was low, and his body seemed to be pushed by a force against the back of the chair. Only then did I know that the lift-off of the plane was not completed at one time, but in several sections. After rising to a certain height, the plane would rise again after flying smoothly.
The feeling when the plane ascended was so wonderful. When I ascended in the first stage, I was a little scared and felt uncomfortable. Fortunately, it was quickly adjusted. When the second stage rose, there was no such strong reaction, and the plane quickly stabilized. Unfortunately, Xishuangbanna is too close to Dali. As soon as I adjusted my condition, the flight attendants began to broadcast, "The plane will land at Dali Airport in 20 minutes". Alas, as they say, the short-haul plane just felt stable and was about to start landing again.
Although this short journey is a bit unpleasant, we have also been on a plane since then, and we have to brag about it when we go back. (Mao Jianling)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31